Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-25 @ 7:35 PM
Study NCT ID:
NCT03562832
Status:
COMPLETED
Last Update Posted:
2025-01-23
First Post:
2018-04-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP
Sponsor:
Allarity Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-26
First Submit QC Date:
None
Study First Post Date:
2018-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-22
Last Update Post Date:
2025-01-23
Last Update Post Date Type:
ACTUAL